PMID- 28754831
OWN - NLM
STAT- MEDLINE
DCOM- 20180312
LR  - 20181202
IS  - 1524-4628 (Electronic)
IS  - 0039-2499 (Linking)
VI  - 48
IP  - 9
DP  - 2017 Sep
TI  - Letter by Shah Regarding Article, "Randomized, Multicenter Trial of ARTSS-2
      (Argatroban With Recombinant Tissue Plasminogen Activator for Acute Stroke)".
PG  - e258
LID - 10.1161/STROKEAHA.117.018121 [doi]
FAU - Shah, Nirav H
AU  - Shah NH
AD  - Swedish Neuroscience Institute, Seattle, WA.
LA  - eng
PT  - Letter
PT  - Comment
DEP - 20170728
PL  - United States
TA  - Stroke
JT  - Stroke
JID - 0235266
RN  - 0 (Fibrinolytic Agents)
RN  - 0 (Pipecolic Acids)
RN  - 0 (Recombinant Proteins)
RN  - EC 3.4.21.68 (Tissue Plasminogen Activator)
RN  - IY90U61Z3S (argatroban)
SB  - IM
CON - Stroke. 2017 Jun;48(6):1608-1616. PMID: 28507269
CIN - Stroke. 2017 Sep;48(9):e259. PMID: 28754829
MH  - Brain Ischemia
MH  - Fibrinolytic Agents
MH  - Humans
MH  - Pipecolic Acids
MH  - Recombinant Proteins
MH  - *Stroke
MH  - *Tissue Plasminogen Activator
MH  - Treatment Outcome
EDAT- 2017/07/30 06:00
MHDA- 2018/03/13 06:00
CRDT- 2017/07/30 06:00
PHST- 2017/07/30 06:00 [pubmed]
PHST- 2018/03/13 06:00 [medline]
PHST- 2017/07/30 06:00 [entrez]
AID - STROKEAHA.117.018121 [pii]
AID - 10.1161/STROKEAHA.117.018121 [doi]
PST - ppublish
SO  - Stroke. 2017 Sep;48(9):e258. doi: 10.1161/STROKEAHA.117.018121. Epub 2017 Jul 28.